Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AEHR NASDAQ:CTKB NASDAQ:LAB NASDAQ:SEER On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAEHRAehr Test Systems$15.47+4.7%$11.48$6.27▼$21.44$460.39M2.291.19 million shs798,623 shsCTKBCytek Biosciences$3.33+2.6%$3.14$2.37▼$7.63$421.14M1.33834,024 shs322,173 shsLABStandard BioTools$1.24-0.4%$1.14$0.92▼$2.41$469.08M1.541.92 million shs431,716 shsSEERSeer$2.15+1.4%$2.08$1.59▼$2.63$126.57M1.57267,370 shs23,439 shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAEHRAehr Test Systems+5.20%+11.21%+25.47%+82.69%-12.23%CTKBCytek Biosciences-0.31%-9.50%-1.82%-11.23%-51.35%LABStandard BioTools+1.64%-8.82%+12.73%+6.90%-45.85%SEERSeer+0.95%-2.30%+4.95%+7.89%+9.84%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAEHRAehr Test Systems1.7962 of 5 stars0.02.00.00.02.92.51.9CTKBCytek Biosciences3.0681 of 5 stars3.14.00.00.02.64.20.0LABStandard BioTools3.826 of 5 stars3.34.00.00.03.83.31.3SEERSeer2.2046 of 5 stars3.02.00.00.01.73.30.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAEHRAehr Test Systems 0.00N/AN/AN/ACTKBCytek Biosciences 2.20Hold$5.6068.42% UpsideLABStandard BioTools 2.50Moderate Buy$2.50102.43% UpsideSEERSeer 2.00Hold$3.0039.53% UpsideCurrent Analyst Ratings BreakdownLatest SEER, LAB, CTKB, and AEHR Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/28/2025CTKBCytek BiosciencesMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$9.00 ➝ $7.005/12/2025CTKBCytek BiosciencesThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetSell ➝ Sell$3.50 ➝ $3.005/9/2025CTKBCytek BiosciencesTD CowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Hold$4.00(Data available from 7/17/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAEHRAehr Test Systems$58.97M7.81$1.32 per share11.73$3.86 per share4.01CTKBCytek Biosciences$197.05M2.14$0.04 per share93.65$3.07 per share1.08LABStandard BioTools$169.69M2.76N/AN/A$1.27 per share0.97SEERSeer$15.06M8.40N/AN/A$5.54 per share0.39Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAEHRAehr Test Systems-$3.91M-$0.13N/A70.34N/A-6.63%-0.15%-0.13%N/ACTKBCytek Biosciences-$6.02M-$0.09N/A∞N/A-5.71%-2.90%-2.30%8/5/2025 (Estimated)LABStandard BioTools-$138.88M-$0.35N/AN/AN/A-78.24%-22.44%-16.74%7/30/2025 (Estimated)SEERSeer-$86.60M-$1.41N/AN/AN/A-560.90%-24.69%-22.13%8/6/2025 (Estimated)Latest SEER, LAB, CTKB, and AEHR EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/14/2025Q2 2025SEERSeer-$0.39N/AN/AN/AN/AN/A8/5/2025Q2 2025CTKBCytek Biosciences-$0.02N/AN/AN/A$46.03 millionN/A7/30/2025Q2 2025LABStandard BioTools-$0.04N/AN/AN/A$39.83 millionN/A7/8/2025Q4 2025AEHRAehr Test Systems-$0.02-$0.01+$0.01-$0.10$14.83 million$14,100.00 billion5/13/2025Q1 2025SEERSeer-$0.37-$0.34+$0.03-$0.34$3.25 million$4.21 million5/8/2025Q1 2025CTKBCytek Biosciences-$0.04-$0.09-$0.05-$0.09$43.18 million$41.46 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAEHRAehr Test SystemsN/AN/AN/AN/AN/ACTKBCytek BiosciencesN/AN/AN/AN/AN/ALABStandard BioToolsN/AN/AN/AN/AN/ASEERSeerN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAEHRAehr Test SystemsN/A5.713.07CTKBCytek BiosciencesN/A5.624.95LABStandard BioToolsN/A6.125.37SEERSeerN/A19.3418.81Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAEHRAehr Test Systems69.69%CTKBCytek Biosciences69.46%LABStandard BioTools53.74%SEERSeer75.20%Insider OwnershipCompanyInsider OwnershipAEHRAehr Test Systems6.20%CTKBCytek Biosciences10.33%LABStandard BioTools23.16%SEERSeer11.28%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAEHRAehr Test Systems9029.77 million27.93 millionOptionableCTKBCytek Biosciences500126.66 million113.58 millionOptionableLABStandard BioTools620379.82 million291.86 millionOptionableSEERSeer16058.87 million52.23 millionOptionableSEER, LAB, CTKB, and AEHR HeadlinesRecent News About These CompaniesOperation Kalanemi: Fake Seer Exposed as Bangladeshi NationalJuly 16 at 7:18 AM | devdiscourse.comDGates fixed at Panchamasali Peetha at Kudala Sangama and locked, but seer has no idea who did itJuly 16 at 7:18 AM | thehindu.comPrime Video’s ‘Bloodaxe’ Adds Six To CastJuly 16 at 7:18 AM | msn.comIn African politics, the rampant belief in witchcraft fortifies some and vexes othersJuly 16 at 7:18 AM | msn.comOld video of Bright The Seer predicting death of former leader emergesJuly 14 at 12:04 PM | gistreel.comGBright the Seer shares what will happen to Bola Tinubu in 2027July 14 at 12:04 PM | msn.comBuhari’s death; Old video of seer predicting former head of state passing emergesJuly 14 at 7:04 AM | gistreel.comGOld video of Bright The Seer predicting death of former Nigerian leader emergesJuly 14 at 7:04 AM | gistreel.comGBuhari’s death: Old prophecy on former head of state’s demise trends, as Bright Seer shares videoJuly 13, 2025 | msn.comVoice of a nation, seer of the West IndiesJuly 13, 2025 | trinidadexpress.comTUttarakhand cracks down on bogus seers, 127 arrested during Kanwar Yatra sweepJuly 12, 2025 | indiatoday.inIHVAC Specialist Dale Admas of Triple A Home Services Shares Insights on SEER Rating and AC Efficiency in HelloNationJuly 12, 2025 | biznes.newseria.plBNo reservation demand until CM change: Panchamasali seerJuly 12, 2025 | uniindia.comUWill not demand 2A reservation as long as Siddaramaiah remains CM, says SeerJuly 12, 2025 | msn.comAl Seer Marine secures AED 760 million financeJuly 11, 2025 | shippingherald.comSAl Seer Marine obtains AED 760 million loan from ADCB for diversified fleet growthJuly 10, 2025 | en.portnews.ruEAl Seer seals $207m loan to drive tanker and gas carrier expansionJuly 10, 2025 | tradewindsnews.comTAbu Dhabi Al Seer Marine secures $207mln facility from ADCBJuly 9, 2025 | zawya.comZAl Seer Marine secures AED760 million financing facility from ADCBJuly 9, 2025 | msn.comAl Seer Marine secures $207mn loan from ADCB to accelerate expansionJuly 9, 2025 | arabianbusiness.comASeer (NASDAQ:SEER) Trading 1.4% Higher - Here's What HappenedJuly 5, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines2 Under the Radar Space & Defense Stocks With Huge PotentialBy Leo Miller | July 1, 2025View 2 Under the Radar Space & Defense Stocks With Huge PotentialRocket Lab: Latest Catalysts Bolster the Bull CaseBy Ryan Hasson | July 3, 2025View Rocket Lab: Latest Catalysts Bolster the Bull CaseThe Meteoric Rise of Rocket Lab: A Space Stock to WatchBy Ryan Hasson | July 11, 2025View The Meteoric Rise of Rocket Lab: A Space Stock to WatchRocket Lab Gets New Street-High Price Target from Citi By Ryan Hasson | July 16, 2025View Rocket Lab Gets New Street-High Price Target from Citi Cantor Boosts Rocket Lab Target to Street-High $35By Ryan Hasson | June 19, 2025View Cantor Boosts Rocket Lab Target to Street-High $35SEER, LAB, CTKB, and AEHR Company DescriptionsAehr Test Systems NASDAQ:AEHR$15.47 +0.69 (+4.70%) As of 03:05 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Aehr Test Systems provides test solutions for testing, burning-in, and semiconductor devices in wafer level, singulated die, and package part form, and installed systems worldwide. Its product portfolio includes FOX-XP and FOX-NP systems that are full wafer contact and singulated die/module test and burn-in systems that can test, burn-in, and stabilize range of devices, including silicon carbide-based and other power semiconductors, 2D and 3D sensors used in mobile phones, tablets and other computing devices, memory semiconductors, processors, microcontrollers, systems-on-a-chip, and photonics and integrated optical devices. The company also offers FOX-CP system, a low-cost single-wafer compact test solution for logic, memory, and photonic devices; FOX WaferPak Contactor, a full wafer contactor capable of testing wafers up to 300mm that enables integrated circuit manufacturers to perform test, burn-in, and stabilization of full wafers on the FOX-P systems. In addition, it provides FOX DiePak Carrier, a reusable temporary package that enables IC manufacturers to perform final test and burn-in of bare die and modules; and FOX DiePak Loader. The company was incorporated in 1977 and is headquartered in Fremont, California.Cytek Biosciences NASDAQ:CTKB$3.32 +0.09 (+2.62%) As of 03:05 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; aurora CS systems; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. The company also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, an automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in European, Latin American, and the Middle Eastern countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.Standard BioTools NASDAQ:LAB$1.24 -0.01 (-0.40%) As of 03:05 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Standard BioTools Inc., together with its subsidiaries, provides instruments, consumables, reagents, and software services for researchers and clinical laboratories in the Americas, Europe, the Middle East, Africa, and the Asia pacific. It operates through two segments: Proteomics and Genomics. The company offers analytical systems, such as CyTOF XT System, a CyTOF XT mass cytometry system performs automated high-parameter single-cell analysis using antibodies conjugated to metal isotopes; and Hyperion XTi imaging system, a spatial biology instrument. It also provides genomics, such as X9 Real-Time PCR System, a real-time PCR analytical instrument including pre-processing steps for microfluidics-based workflows using (integrated fluidic circuit) IFCs; and IFC Controllers, a controller which is designed to work with IFC formats. In addition, the company offers analytical instruments comprising Biomark HD system, a real-time PCR analytical instrument for microfluidics-based workflows using prepared IFCs. It sells its products to academic research institutions; translational research and medicine centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology, and plant and animal research companies; and contract research organizations. It has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Fluidigm Corporation and changed its name to Standard BioTools Inc. in April 2022. Fluidigm Corporation was incorporated in 1999 and is headquartered in South San Francisco, California.Seer NASDAQ:SEER$2.15 +0.03 (+1.42%) As of 03:04 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. The company intends to sell its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It operates in China, Australia, Eastern Europe, Israel, and Japan. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Is Amazon Really the Best Forever Stock for Your Portfolio? Qualcomm: Undervalued Chip Stock in Breakout Uptrend Broadcom’s Takes on NVIDIA: Why Tomahawk Ultra Could Boost Shares CrowdStrike Bulls Beware: This Trade May Be Getting Crowded AMD Just Triggered a Signal Traders Can’t Ignore JNJ’s Stock Price Is Back in Rally Mode—The Time to Buy Is Now Citigroup Earnings Could Signal What’s Next for Markets This ASML Dip Could Be Gone Before You Know It—Don’t Miss Out Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
